bell
The current prices are delayed by 15 mins, login to check live prices.
Syncom Formulations (India) Ltd share price logo

Syncom Formulations (India) Ltd Share Price

(SYNCOMF)

₹17.952.39%

as on 01:15PM, 22 Jan 2025

Overview
News
Financials
Q3 2024 Results
Technicals

Syncom Formulations (India) Ltd Performance

  • Day's Low

    Day's High

    ₹17.7
    Day's Price Range
    ₹18.49
  • 52 Week's Low

    52 Week's High

    ₹10.95
    52-Week Price Range
    ₹27.9
1 Month Return-8.82 %
3 Month Return-3.46 %
1 Year Return+ 21.79 %
Previous Close₹18.39
Open₹17.83
Volume17.48L
Upper Circuit-
Lower Circuit-
Market Cap₹1,728.66Cr

Syncom Formulations (India) Ltd Key Statistics

P/E Ratio39.98
PEG Ratio266.52
Market Cap₹1,728.66 Cr
P/B Ratio3.67
EPS0.27
Dividend Yield0
SectorPharmaceuticals
ROE8.71

Syncom Formulations (India) Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹1,728.66 Cr483.84%0.61₹25 Cr₹263 Cr
BUY₹12,423.88 Cr-3.8%0.52₹602 Cr₹2,851 Cr
NA₹1,067.07 Cr-1.52%0.56₹41 Cr₹338 Cr
NA₹561.76 Cr128.49%0.69-₹3 Cr₹111 Cr
NA₹3,528.84 Cr766.04%0.51NANA

Syncom Formulations (India) Ltd Mutual Fund Holdings

About Syncom Formulations (India) Ltd

Syncom Formulations India is a public limited company that was established in 1988 and converted to public limited in 1992. It manufactures pharmaceutical formulations, injectibles, ear/eye drops, and herbal products such as Edicare Attom Megacaps Ecziguard and Yas antacid salt. The company started its expansion project in 1994 of setting up a new manufacturing plant in Pithampur Madhya Pradesh which was completed in 1995. During the financial year 1998-99, big expansions in the installed capacity and production base, and the introduction of products in the generic OTC and Ethical divisions were made. The exports boasted an increase of more than 100% and received orders worth Rs.700 lacs. It has been approved as a supplier to Central ESI Hospitals and registered for defence services that will augment the sales volume. Syncom Formulations India is continuously working towards growth and aims to significantly increase its product portfolio and customer base.

Share Price: ₹17.95 per share as on 22 Jan, 2025 01:15 PM
Market Capitalisation: ₹1,728.66Cr as of today
Revenue: ₹102.31Cr as on September 2024 (Q3 24)
Net Profit: ₹11.11Cr as on September 2024 (Q3 24)
Listing date: 18 Nov, 2022
Chairperson Name: Kedarmal Bankda
OrganisationSyncom Formulations (India) Ltd
HeadquartersIndore
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Syncom Formulations (India) Ltd

  • Syncom Formula Reports Strong Q2 Growth - 25 Nov, 2024

    Syncom Formula Consolidated reported a 60.27% increase in net sales to Rs 102.31 crore for September 2024, with net profit rising 70.59% to Rs 11.11 crore. The company's EPS doubled to Rs 0.16. Shares closed at Rs 19.50, yielding 47.73% returns over six months and 77.27% over twelve months.
  • Syncom Formula Reports Strong Q2 Growth - 13 Nov, 2024

    Syncom Formula's standalone net sales for September 2024 reached Rs 101.49 crore, up 62.68% YoY. Net profit increased by 76.46% to Rs 10.95 crore, with EBITDA rising 59.5%. The EPS doubled to Rs 0.16. The stock has shown impressive returns of 62.45% over six months and 106.83% over twelve months.

Insights on Syncom Formulations (India) Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 6 quarters, 4.4 Cr → 11.11 Cr (in ₹), with an average increase of 15.8% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 6 quarters, 61.71 Cr → 106.46 Cr (in ₹), with an average increase of 10.2% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.09% to 0.10% in Sep 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 50.57% of holdings in Sep 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 103.2% return, outperforming this stock by 105.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 46.6% return, outperforming this stock by 38.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SYNCOMF stock has moved down by -11.9%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 49.34% to 49.33% in Sep 2024 quarter

Syncom Formulations (India) Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹63.84Cr (-)₹65.14Cr (↑2.04%)₹74.57Cr (↑14.48%)₹86.29Cr (↑15.72%)₹102.31Cr (↑18.57%)
Net Income₹6.51Cr (-)₹7.00Cr (↑7.53%)₹7.40Cr (↑5.71%)₹7.63Cr (↑3.11%)₹11.11Cr (↑45.61%)
Net Profit Margin10.20% (-)10.75% (↑5.39%)9.92% (↓7.72%)8.84% (↓10.89%)10.86% (↑22.85%)
Value in ₹ crore
Details2021202220232024
Total Assets₹292.03Cr (-)₹308.83Cr (↑5.75%)₹377.62Cr (↑22.27%)₹392.33Cr (↑3.90%)
Total Liabilities₹104.44Cr (-)₹86.60Cr (↓17.08%)₹121.61Cr (↑40.43%)₹105.88Cr (↓12.93%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹5.86Cr (-)-₹2.06Cr (↓135.15%)₹16.33Cr (↓892.72%)₹10.50Cr (↓35.70%)-₹5.94Cr (↓156.57%)

Index Inclusions

BSE Healthcare

₹42,310.09

-0.62 (-263.58%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

BSE Small-Cap

₹50,409.23

-2.52 (-1305.39%)

Syncom Formulations (India) Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
50.57%
0.00
Foreign Institutions
0.1%
16.05
Mutual Funds
0%
100.00
Retail Investors
49.33%
-0.03
Others
0%
0.00

Syncom Formulations (India) Ltd Key Indicators

Details20162017202220232024
Earning Per Share (₹)0.130.130.230.210.27
Details20202021202220232024
Return On Equity %10.2417.519.668.398.71
Details20232024
Return On Assets %5.316.45
Details20162017202220232024
Book Value Per Share (₹)1.391.52.522.723.07

Syncom Formulations (India) Ltd Valuation

Syncom Formulations (India) Ltd in the last 5 years

  • Overview

  • Trends

Lowest (3.98x)

March 12, 2020

Today (39.98x)

January 21, 2025

Industry (55.69x)

January 21, 2025

Highest (81.74x)

January 18, 2022

LowHigh

Syncom Formulations (India) Ltd Earnings and Dividends

  • Syncom Formulations (India) Ltd Earnings Results

    Syncom Formulations (India) Ltd’s net profit jumped 70.66% since last year same period to ₹11.11Cr in the Q2 2024-2025. On a quarterly growth basis, Syncom Formulations (India) Ltd has generated 45.61% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Syncom Formulations (India) Ltd Dividends August,2022

    In the quarter ending June 2022, Syncom Formulations (India) Ltd has declared dividend of ₹0.03 - translating a dividend yield of 0.16%.

    Read More about Dividends

Syncom Formulations (India) Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Syncom Formulations (India) Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Syncom Formulations (India) Ltd

Syncom Formulations (India) Ltd share price today stands at ₹17.95, Open. ₹17.83 ; Previous Close. ₹18.39 ; High. ₹18.49 ; Low. ₹17.7 ; 52 Week High. ₹27.9 ; 52 Week Low: ₹10.95.

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Syncom Formulations (India) Ltd shares.

Syncom Formulations (India) Ltd is listed on NSE

Syncom Formulations (India) Ltd is listed on BSE

  • Today’s highest price of Syncom Formulations (India) Ltd is ₹18.49.
  • Today’s lowest price of Syncom Formulations (India) Ltd is ₹17.7.

PE Ratio of Syncom Formulations (India) Ltd is 39.98

PE ratio = Syncom Formulations (India) Ltd Market price per share / Syncom Formulations (India) Ltd Earnings per share

Today’s traded volume of Syncom Formulations (India) Ltd(SYNCOMF) is 17.48L.

Today’s market capitalisation of Syncom Formulations (India) Ltd(SYNCOMF) is ₹1728.66Cr.

Syncom Formulations (India) Ltd(SYNCOMFPrice
52 Week High
₹27.9
52 Week Low
₹10.95

Syncom Formulations (India) Ltd(SYNCOMF) share price is ₹17.95. It is down -35.66% from its 52 Week High price of ₹27.9

Syncom Formulations (India) Ltd(SYNCOMF) share price is ₹17.95. It is up 63.93% from its 52 Week Low price of ₹10.95

Syncom Formulations (India) Ltd(SYNCOMFReturns
1 Day Returns
-0.44%
1 Month Returns
-8.82%
3 Month Returns
-3.46%
1 Year Returns
21.79%